Briacell Therapeutics Corp T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp

Bullboard Posts

Comment by netstarson Sep 07, 2011 1:19pm

221 Views

Post# 19018548

RE: The real reason the stock is down on great dri

You may be right, but there's no evidence to suggest that Coglon has sold any shares - at least not on SEDI since January 1, 2011 or on TSX insider trading records for yesterday. Some insiders have sold, but above
.50 in May. Others have been buying. One PP in May at
.32 was unbrokered. This is always a good sign.It's likely that ACP's share price is suffering because people are profit taking down to previous levels and others are selling because the spot gold price is down $100 in two days. As a result, a third group is selling because they are afraid to hold.All just my opinion.GTLA

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading